drugset / Trial / NCT01442272
Value Antiproteinuric Effects From Vitamin D Derivatives in Patient With Chronic Kidney Illness and the Lack of Vitamin D
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the value the additional antiproteinuric effects of vitamin D derivatives treatment, in patients with Chronic Kidney Illness phase II-IV, with lack of vitamin D and residual proteinuria higher 0,5 grams/day.
Timeline
- Start
- 2012-01
- Primary completion
- 2012-10
- Completion
- 2013-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Calcifediol | Unknown | 266 ug | Oral |
| Comparator | Paricalcitol | Other / unclassified | 1 ug | Oral |